| Krystal Biotech, Inc. | 1.14M | US$379M | 13.5% |
| Insulet Corporation | 1.73M | US$225M | 8.0% |
| TG Therapeutics, Inc. | 2.56M | US$143M | 5.1% |
| United Therapeutics Corporation | 259K | US$140M | 5.0% |
| Celcuity Inc. | 1.68M | US$134M | 4.8% |
| Rigel Pharmaceuticals, Inc. | 1.84M | US$88.8M | 3.2% |
| Inspire Medical Systems, Inc. | 1.21M | US$83.7M | 3.0% |
| Erasca, Inc. | 5.11M | US$74.9M | 2.7% |
| Beta Bionics, Inc. | 3.74M | US$71.1M | 2.5% |
| ANI Pharmaceuticals, Inc. | 976K | US$70.9M | 2.5% |
| Vericel Corporation | 1.55M | US$62.4M | 2.2% |
| Geron Corporation | 46.8M | US$57.5M | 2.0% |
| Parabilis Medicines, Inc. | 1.68M | US$54.4M | 1.9% |
| argenx SE | 49,350 | US$47.3M | 1.7% |
| Axogen, Inc. | 1.08M | US$45.3M | 1.6% |
| NeuroPace, Inc. | 3.22M | US$44.3M | 1.6% |
| Evolus, Inc. Common Stock | 5.09M | US$40.7M | 1.4% |
| Zai Lab Ltd. | 1.54M | US$40.6M | 1.4% |
| Progyny, Inc. | 1.58M | US$39.9M | 1.4% |
| Trevi Therapeutics, Inc. | 2.73M | US$39.1M | 1.4% |
| Nuvectis Pharma, Inc. | 1.71M | US$36.1M | 1.3% |
| Edap Tms SA | 7.31M | US$32.7M | 1.2% |
| Avalyn Pharma Inc. | 1.02M | US$29M | 1.0% |
| Kodiak Sciences Inc | 287K | US$27.2M | 0.97% |
| Silence Therapeutics PLC | 2.39M | US$26.1M | 0.93% |
| Inhibikase Therapeutics, Inc. | 11.2M | US$23.1M | 0.82% |
| Arcus Biosciences, Inc. | 862K | US$22.3M | 0.79% |
| Legend Biotech Corp. | 1.09M | US$21.6M | 0.77% |
| Nurix Therapeutics, Inc. | 892K | US$21.2M | 0.75% |
| Inhibrx Biosciences, Inc. | 210K | US$21M | 0.75% |
| Adlai Nortye Group Ltd. | 1.27M | US$20.4M | 0.72% |
| Palisade Bio, Inc. | 15M | US$20.2M | 0.72% |
| Tango Therapeutics, Inc. | 802K | US$20M | 0.71% |
| Biodesix, Inc. | 668K | US$19.9M | 0.71% |
| Insmed Incorporated | 147K | US$16.8M | 0.60% |
| Praxis Precision Medicines, Inc. | 56,515 | US$16.5M | 0.59% |
| Jade Biosciences, Inc. | 1.17M | US$16.5M | 0.58% |
| CONMED Corporation | 347K | US$16.1M | 0.57% |
| Eton Pharmaceuticals, Inc. | 308K | US$15.9M | 0.56% |
| OrthoPediatrics Corp. | 710K | US$15.8M | 0.56% |
| Organogenesis Holdings Inc. | 11.3M | US$15.5M | 0.55% |
| GRAIL, Inc. | 109K | US$15.2M | 0.54% |
| MBX Biosciences, Inc. | 259K | US$15.2M | 0.54% |
| Edgewise Therapeutics, Inc. | 330K | US$13.4M | 0.48% |
| Amneal Pharmaceuticals, Inc. | 658K | US$13.3M | 0.47% |
| Prelude Therapeutics Incorporated | 3.38M | US$13.2M | 0.47% |
| Septerna, Inc. | 330K | US$12.9M | 0.46% |
| Syndax Pharmaceuticals, Inc. | 616K | US$11.6M | 0.41% |
| Sanofi SA | 275K | US$11.3M | 0.40% |
| C4 Therapeutics, Inc. | 3.36M | US$11.2M | 0.40% |
| PROCEPT BioRobotics Corporation | 600K | US$10.9M | 0.39% |
| Tyra Biosciences, Inc. | 445K | US$9.73M | 0.35% |
| Twist Bioscience Corporation | 47,532 | US$9.19M | 0.33% |
| Iovance Biotherapeutics, Inc. | 552K | US$8.18M | 0.29% |
| Xenon Pharmaceuticals Inc. | 205K | US$7.62M | 0.27% |
| Revolution Medicines, Inc. | 36,249 | US$7.44M | 0.26% |
| BioMarin Pharmaceutical Inc. | 121K | US$7.27M | 0.26% |
| Capricor Therapeutics, Inc. | 699K | US$6.62M | 0.24% |
| Invivyd, Inc. | 7.52M | US$6.55M | 0.23% |
| Pulmonx Corporation | 3.09M | US$5.9M | 0.21% |
| Avalo Therapeutics, Inc. | 384K | US$5.88M | 0.21% |
| Castle Biosciences, Inc. | 141K | US$5.01M | 0.18% |
| First Tracks Biotherapeutics, Inc. | 141K | US$4.98M | 0.18% |
| Glaukos Corporation | 25,552 | US$4.2M | 0.15% |
| TCGX Acquisition Corp. | 225K | US$2.81M | 0.10% |
| Electra Therapeutics, Inc. | 250K | US$2.81M | 0.10% |
| Satellos Bioscience Inc | 330K | US$2.81M | 0.10% |
| Solid Biosciences Inc. | 368K | US$2.66M | 0.09% |
| SAB Biotherapeutics, Inc. | 672K | US$2.13M | 0.08% |
| Context Therapeutics Inc. | 7.06M | US$2.12M | 0.08% |
| Zentalis Pharmaceuticals, Inc. | 706K | US$1.96M | 0.07% |
| Tandem Diabetes Care, Inc. | 100K | US$1.63M | 0.06% |
| Waystar Holding Corp. | 50,000 | US$1.27M | 0.05% |
| MannKind Corporation | 300K | US$1.17M | 0.04% |
| Cerus Corporation | 450K | US$1.07M | 0.04% |
| Aprea Therapeutics, Inc. | 1M | US$750K | 0.03% |
| InspireMD Inc. | 1.05M | US$698K | 0.02% |
| NextCure, Inc. | 90,000 | US$451K | 0.02% |
| Indivior Pharmaceuticals, Inc. | 10,000 | US$359K | 0.01% |
| Processa Pharmaceuticals, Inc. | 161K | US$264K | <0.01% |
| Belite Bio, Inc. | 1,524 | US$259K | <0.01% |
| BioNTech SE | 2,500 | US$246K | <0.01% |
| UnitedHealth Group Incorporated | 660 | US$242K | <0.01% |
| Vir Biotechnology, Inc. | 20,971 | US$234K | <0.01% |
| QuidelOrtho Corporation | 20,000 | US$211K | <0.01% |
| Attovia Therapeutics, Inc. | 10,000 | US$171K | <0.01% |
| Equillium, Inc. | 90,000 | US$146K | <0.01% |
| RxSight, Inc. | 20,000 | US$98,000 | <0.01% |
| CG Oncology, Inc. | 0 | US$0 | 0.00% |
| Corcept Therapeutics Incorporated | 0 | US$0 | 0.00% |
| Cullinan Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Enliven Therapeutics, Inc. | 0 | US$0 | 0.00% |
| GeneDx Holdings Corp. | 0 | US$0 | 0.00% |
| Globus Medical, Inc. | 0 | US$0 | 0.00% |
| Immunic, Inc. | 0 | US$0 | 0.00% |
| Immunovant, Inc. | 0 | US$0 | 0.00% |
| Karyopharm Therapeutics Inc. | 0 | US$0 | 0.00% |
| Larimar Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Merck & Company, Inc. | 0 | US$0 | 0.00% |
| Mirum Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |